Landipirdine Uses, Dosage, Side Effects and more
Landipirdine is under investigation in clinical trial NCT02258152 (SYN120 Study to Evaluate Its Safety, Tolerability and Efficacy in Parkinson's Disease Dementia (SYNAPSE)).
| Attribute | Details |
|---|---|
| Trade Name | Landipirdine |
| Generic | Landipirdine |
| Landipirdine Other Names | Landipirdine |
| Type | |
| Formula | C18H19FN2O3S |
| Weight | Average: 362.42 Monoisotopic: 362.110041817 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
